Avidea Technologies Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

Avidea Technologies General Information

Description

Developer of immunotherapies intended to treat cancer and autoimmune diseases. The company offers polymer-drug conjugate technologies namely SNAPvax which is a vaccine platform for inducing T cell immunity and can be repeatedly administered by the intravenous route to maximize efficacy, and it offers Syntholytic that uses dual responsiveness to selectively target and release immunostimulants in tumors to maximize tumor killing while mitigating systemic toxicity, enabling patients to have fast recovery options instead of off-target side effects.

Contact Information

Website
www.avideatechnologies.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Baltimore, MD
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Acquirer
Barinthus Biotherapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Baltimore, MD
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avidea Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 10-Dec-2021 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2018 Completed Pre-Clinical Trials
1. Early Stage VC 01-Sep-2017 Completed Startup
To view Avidea Technologies’s complete valuation and funding history, request access »

Avidea Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunotherapies intended to treat cancer and autoimmune diseases. The company offers polymer-drug conjugate
Biotechnology
Baltimore, MD
15 As of 2021

Cambridge, MA

Oslo, Norway
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avidea Technologies Competitors (3)

One of Avidea Technologies’s 3 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Formerly VC-backed Cambridge, MA
Nykode Formerly PE-Backed Oslo, Norway
BioNTech Formerly VC-backed Mainz, Germany
You’re viewing 3 of 3 competitors. Get the full list »

Avidea Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avidea Technologies Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biohealth Innovation Corporation Minority
Johns Hopkins Technology Ventures Accelerator/Incubator Minority
To view Avidea Technologies’s complete investors history, request access »

Ready to get started?

Request a free trial

Avidea Technologies FAQs

  • When was Avidea Technologies founded?

    Avidea Technologies was founded in 2013.

  • Where is Avidea Technologies headquartered?

    Avidea Technologies is headquartered in Baltimore, MD.

  • What is the size of Avidea Technologies?

    Avidea Technologies has 15 total employees.

  • What industry is Avidea Technologies in?

    Avidea Technologies’s primary industry is Biotechnology.

  • Is Avidea Technologies a private or public company?

    Avidea Technologies is a Private company.

  • What is the current valuation of Avidea Technologies?

    The current valuation of Avidea Technologies is .

  • What is Avidea Technologies’s current revenue?

    The current revenue for Avidea Technologies is .

  • Who are Avidea Technologies’s investors?

    Biohealth Innovation and Johns Hopkins Technology Ventures have invested in Avidea Technologies.

  • Who are Avidea Technologies’s competitors?

    AnTolRx, Nykode, and BioNTech are competitors of Avidea Technologies.

  • When was Avidea Technologies acquired?

    Avidea Technologies was acquired on 10-Dec-2021.

  • Who acquired Avidea Technologies?

    Avidea Technologies was acquired by Barinthus Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process